Automated Insulin Delivery: Tandem Diabetes Unveils Control-IQ+ Enhancements

What You Should Know: 

– Tandem Diabetes Care, a leader in insulin delivery and diabetes technology announced the U.S. commercial launch of Control-IQ+ technology. 

– This update provides users with greater flexibility and control over their diabetes management. The expanded parameters and enhanced features of Control-IQ+ are designed to address a broader range of individual needs, making automated insulin delivery more accessible and effective.

Automated Insulin Delivery Technology 

Control-IQ+ is compatible with both the t:slim X2 insulin pump and the Tandem Mobi System, and is now available for individuals with type 1 diabetes ages 2 years and older, as well as adults with type 2 diabetes. New pumps pre-loaded with the updated software are now being shipped to new customers. Importantly, all eligible, in-warranty Tandem customers will receive access to the new features via a free, remote software update.

Control-IQ+ builds upon the foundation of Tandem’s existing Control-IQ algorithm, which already features:

• Automated Insulin Adjustments: The system adjusts insulin delivery every 5 minutes based on predicted glucose values.
• AutoBolus™ Feature: A unique AutoBolus™ feature calculates and delivers a correction bolus to help manage missed meal boluses.
• Extended Bolus Capability: Control-IQ+ is the only AID algorithm that allows users to program extended boluses of up to 8 hours while automation is active.

“These new features allow for even greater levels of personalization and flexibility within our algorithm, while still receiving high marks for ease of use across a diverse population of users,” said John Sheridan, president and chief executive officer. “We are proud to offer this life-changing technology to millions more people living with diabetes.”

All eligible, in-warranty Tandem users can access the software update by logging into their Tandem Source account: https://source.tandemdiabetes.com.